A Phase 2, Open-Label, Multi-Center Study of Venetoclax in Combination with Carfilzomib and Dexamethasone in Subjects with Relapsed or Refractory Multiple Myeloma

Administered By

Awarded By

Contributors

Start/End

  • May 22, 2018 - February 28, 2023